Hypertension with metabolic syndrome in patients with different degrees of plasma lipoprotein (a) levels observed.docVIP

 PAGE \* MERGEFORMAT 8 Hypertension with metabolic syndrome in patients with different degrees of plasma lipoprotein (a) levels observed [Abstract] Objective To study the different degrees of hypertensive patients with metabolic syndrome with plasma lipoprotein (a) and its clinical significance. Methods in patients with essential hypertension in 100 patients with metabolic syndrome, according to hypertension patients with metabolic syndrome divided into 3 groups: a metabolic disorder with another; metabolic abnormalities associated with the other two; with the other three or more metabolic abnormalities. using automatic biochemical analyzer determination of plasma total cholesterol, triglyceride and lipid protein (a) levels. Results hypertensive patients with metabolic syndrome was significantly associated with lipid metabolism disorders, lipoprotein (a) levels with the concomitant increase in the number of metabolic syndrome was significantly higher (P lt;0.05), The total cholesterol and triglyceride levels were not significantly different (Pgt; 0.05). Conclusions The plasma lipoprotein (a) levels and metabolic syndrome is closely related to essential hypertension as a hint there are other metabolic abnormalities in patients with clinical clues. [Keywords:] hypertension; metabolic syndrome; Lipoprotein (a); lipid Abstract: Objective To investigate the relationship between plasma lipoprotein (a) concentration with in patients with essential hypertension and metabolic syndrome. Methods The serum concentration of total cholesterol, triglyceride and Lipoprotein (a) in 100 patients with essential hypertension and metabolic syndrome was measured enzymatically . According to the number of Abnormal lipid metabolism hypertensive patients were divided into three groups, and analyze level of Lipoprotein (a) among three group. Results There are significantly abnormal lipid metabolism in patients with essential hypertension and metabolic syndrome. Plasma lipopr